2021
DOI: 10.1177/09727531211046369
|View full text |Cite
|
Sign up to set email alerts
|

DMSO Delays Alzheimer Disease Causing Aβ-induced Paralysis in C. elegans Through Modulation of Glutamate/Acetylcholine Neurotransmission

Abstract: Background: Alzheimer’s disease (AD), a prevalent neurodegenerative disease with progressive dementia and neurotransmission (NT)-dysfunction-related complications in older adults, is known to be caused by abnormal Amyloid-β (Aβ) peptide and associated amyloid plaques in the brain. Drugs to cure AD are not in sight. Two major excitatory neurotransmitters, glutamate (Glu) and acetylcholine (ACh), and their signaling systems are implicated in AD. Objective: To determine the effect of various NT-altering compounds… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 51 publications
0
3
0
Order By: Relevance
“…For the same conditions as that in LMT1 groups, Dimethyl sulfoxide (DMSO) (1%, v/v) was used in the vehicle group, which would lead to the delayed onset of worm paralysis. [ 42 ] Compared to the vehicle group, treatment with cis‐LMT1 and irradiation at 365 nm obviously postponed the paralysis (Figure 7B), suggesting that cis‐LMT1 could alleviate the neurotoxicity of Aβ aggregation in C. elegans by blocking the aggregation via freezing Aβ42 dimers. In the dark, almost no delay in paralysis was observed in worms treated with trans‐LMT1, confirming that trans‐LMT1 cannot intervene Aβ aggregation in vivo.…”
Section: Resultsmentioning
confidence: 99%
“…For the same conditions as that in LMT1 groups, Dimethyl sulfoxide (DMSO) (1%, v/v) was used in the vehicle group, which would lead to the delayed onset of worm paralysis. [ 42 ] Compared to the vehicle group, treatment with cis‐LMT1 and irradiation at 365 nm obviously postponed the paralysis (Figure 7B), suggesting that cis‐LMT1 could alleviate the neurotoxicity of Aβ aggregation in C. elegans by blocking the aggregation via freezing Aβ42 dimers. In the dark, almost no delay in paralysis was observed in worms treated with trans‐LMT1, confirming that trans‐LMT1 cannot intervene Aβ aggregation in vivo.…”
Section: Resultsmentioning
confidence: 99%
“…Some studies also indicated lutein and EGCG preferentially display beneficial effects in compromised C. elegans backgrounds [45,46], while others have shown the compounds increase stress resistance and extend lifespan also in wild-type animals [47,48]. These seemingly conflicting results can be explained by different exposure scenarios: bimodal dose-dependent effects have been often reported with dietary interventions [47,49]; different bacterial types used as food source (e.g., HT115 vs OP50; dead vs alive bacteria) can influence animals phenotypes and behaviors in basal conditions, as well as compounds metabolism and therefore their biological effects on lifespan and age-associated features [50][51][52]; vehicles, methods and age of administration may add further variability [53][54][55]. For instance, we here observed that different experimental paradigms (e.g., ±solvent) slightly affect resistance to stress and attraction to food in the nAD strain compared to wild-type animals.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, differently from the original study [30], the nAD strain, which we fed here HT115 plus vehicle, was not short lived compared to wild-type animals. Interestingly, DMSO, the most commonly used solvent used for compound feeding, has been shown to have repercussion on a broad spectrum of animals' phenotypes including lifespan [50][51][52].…”
Section: Discussionmentioning
confidence: 99%